The use of methyluracil and levamisole in patients with diabetes mellitus
- Authors: Morugova T.V.1
-
Affiliations:
- Department of Hospital Therapy No. 2 and Central Scientific Research Laboratory of the Bashkir Medical Institute
- Issue: Vol 63, No 2 (1982)
- Pages: 35-37
- Section: Articles
- URL: https://ogarev-online.ru/kazanmedj/article/view/60723
- DOI: https://doi.org/10.17816/kazmj60723
- ID: 60723
Cite item
Full Text
Abstract
The inclusion of methyluracil in the complex treatment of patients with diabetes mellitus leads to a more pronounced increase in the phagocytic index and a slight increase in the titers of natural agglutinins and antibodies to alpha-staphyllisin. Levamisole significantly increases the content of T-lymphocytes. As a stimulant of immunity in diabetes mellitus, it is more advisable to use methyluracil, which is an anabolic and antioxidant.
Keywords
Full Text
##article.viewOnOriginalSite##About the authors
T. V. Morugova
Department of Hospital Therapy No. 2 and Central Scientific Research Laboratory of the Bashkir Medical Institute
Author for correspondence.
Email: info@eco-vector.com
Russian Federation, Russia
References
Supplementary files
